ACAT1 and lung adenocarcinoma: In EGFR-mutant lung adenocarcinoma, SIRT5 suppresses CD8+ T-cell recruitment through an ACAT1–NRF2 succinylation axis, providing an additional layer of suppression that limits responsiveness to checkpoint blockade (161).